Market Cap 22.55M
Revenue (ttm) 86.55M
Net Income (ttm) -56.70M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -65.51%
Debt to Equity Ratio 3.60
Volume 37,200
Avg Vol 60,225
Day's Range N/A - N/A
Shares Out 4.51M
Stochastic %K 6%
Beta 1.57
Analysts Sell
Price Target $60.00

Company Profile

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific me...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 508 893 8999
Fax: 508 429 5732
Address:
84 October Hill Road, Suite 10, Holliston, United States
Axen7
Axen7 May. 12 at 6:19 PM
$HBIO glad sold when I did. Was not a fan of this earnings. Increased debt was not what I wanted. It was a classic pump into earnings followed by a sell off. GL here though bulls
0 · Reply
SuperGreenToday
SuperGreenToday May. 12 at 12:38 PM
$HBIO Share Price: $6.89 Contract Selected: Aug 21, 2026 $4.0 Calls Buy Zone: $0.04 – $0.05 Target Zone: $0.07 – $0.08 Potential Upside: 67% ROI Time to Expiration: 100 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
EarningsInsider
EarningsInsider May. 12 at 12:31 PM
https://www.marketbeat.com/earnings/reports/2026-5-12-harvard-bioscience-inc-stock/ $HBIO Harvard Bioscience Earnings Transcript
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 12 at 11:36 AM
$HBIO Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.08 up 99.30% YoY • Reported revenue of $20.75M down -4.68% YoY • Harvard Bioscience reaffirms full-year 2026 guidance, anticipating revenue growth of 2% to 4%, adjusted gross margin of 58% to 60%, and adjusted EBITDA growth of 6% to 10%.
0 · Reply
Axen7
Axen7 May. 6 at 5:30 PM
$HBIO I am outtie all. Taking my profits finally. The low volume and uptrend is kind of reminding me of another stock I didn’t sell, for it to just get halved by an offering by the company in seconds. Gl to all here and crush it.
1 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 28 at 2:24 PM
$HBIO RSI: 60.36, MACD: 0.4121 Vol: 0.83, MA20: 5.80, MA50: 5.57 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Axen7
Axen7 Apr. 21 at 4:01 PM
$HBIO stop do the go down. Do the go up!
0 · Reply
Don_Frye
Don_Frye Apr. 20 at 7:10 PM
$NKTR $OTLK $HBIO $BYND what a day
0 · Reply
GTMStox
GTMStox Apr. 20 at 2:37 PM
$HBIO Looks like we got some volume coming in today
0 · Reply
Axen7
Axen7 Apr. 17 at 3:01 PM
$HBIO do the thing and don’t stops! Release some banger news for us one time!
0 · Reply
Latest News on HBIO
Harvard Bioscience reiterates Q2 revenue view $20.5M-$22.5M

2026-05-12T13:59:42.000Z - 7 days ago

Harvard Bioscience reiterates Q2 revenue view $20.5M-$22.5M


Harvard Bioscience reaffirms FY26 revenue growth of 2%-4%

2026-05-12T13:45:49.000Z - 7 days ago

Harvard Bioscience reaffirms FY26 revenue growth of 2%-4%


Harvard Bioscience Earnings Call Transcript: Q1 2026

May 12, 2026, 8:00 AM EDT - 7 days ago

Harvard Bioscience Earnings Call Transcript: Q1 2026


Harvard Bioscience Earnings release: Q1 2026

May 12, 2026, 8:00 AM EDT - 7 days ago

Harvard Bioscience Earnings release: Q1 2026


Harvard Bioscience Slides: Q1 2026

May 12, 2026, 8:00 AM EDT - 7 days ago

Harvard Bioscience Slides: Q1 2026


Harvard Bioscience Quarterly report: Q1 2026

May 12, 2026, 8:00 AM EDT - 7 days ago

Harvard Bioscience Quarterly report: Q1 2026


Harvard Bioscience Slides: Investor presentation

May 12, 2026, 7:00 AM EDT - 7 days ago

Harvard Bioscience Slides: Investor presentation


Harvard Bioscience Proxy statement: Proxy filing

Apr 21, 2026, 8:00 AM EDT - 4 weeks ago

Harvard Bioscience Proxy statement: Proxy filing


Harvard Bioscience Proxy statement: Proxy filing

Apr 21, 2026, 8:00 AM EDT - 4 weeks ago

Harvard Bioscience Proxy statement: Proxy filing


Harvard Bioscience Slides: FY 2026

Mar 17, 2026, 2:15 PM EDT - 2 months ago

Harvard Bioscience Slides: FY 2026


Harvard Bioscience trading halted, news pending

2026-03-13T23:56:02.000Z - 2 months ago

Harvard Bioscience trading halted, news pending


Harvard Bioscience Earnings Call Transcript: Q4 2025

Mar 12, 2026, 8:00 AM EDT - 2 months ago

Harvard Bioscience Earnings Call Transcript: Q4 2025


Harvard Bioscience Annual report: Q4 2025

Mar 12, 2026, 8:00 AM EDT - 2 months ago

Harvard Bioscience Annual report: Q4 2025


Harvard Bioscience Earnings release: Q4 2025

Mar 12, 2026, 8:00 AM EDT - 2 months ago

Harvard Bioscience Earnings release: Q4 2025


Harvard Bioscience Slides: Q4 2025

Mar 12, 2026, 8:00 AM EDT - 2 months ago

Harvard Bioscience Slides: Q4 2025


Harvard Bioscience reports Q4 adjusted EPS (0c) vs 6c last year

2026-03-12T11:41:52.000Z - 2 months ago

Harvard Bioscience reports Q4 adjusted EPS (0c) vs 6c last year


Harvard Bioscience appoints interim CFO Mark Frost as CFO

2026-03-12T11:41:33.000Z - 2 months ago

Harvard Bioscience appoints interim CFO Mark Frost as CFO


Harvard Bioscience sees Q1 revenue $20M-$22M

2026-03-12T11:41:25.000Z - 2 months ago

Harvard Bioscience sees Q1 revenue $20M-$22M


Harvard Bioscience sees FY26 revenue growth 2%-4%

2026-03-12T11:40:54.000Z - 2 months ago

Harvard Bioscience sees FY26 revenue growth 2%-4%


Harvard Bioscience announces 1-for-10 reverse stock split

2026-03-06T21:05:29.000Z - 2 months ago

Harvard Bioscience announces 1-for-10 reverse stock split


Harvard Bioscience Announces Reverse Stock Split

Mar 6, 2026, 4:01 PM EST - 2 months ago

Harvard Bioscience Announces Reverse Stock Split


Harvard Bioscience Transcript: EGM 2026

Mar 6, 2026, 10:00 AM EST - 2 months ago

Harvard Bioscience Transcript: EGM 2026


Harvard Bioscience outlines strategy for growth

2026-02-10T12:41:11.000Z - 3 months ago

Harvard Bioscience outlines strategy for growth


Harvard Bioscience reports preliminary Q4 revenue $23.7M

2026-02-10T12:35:19.000Z - 3 months ago

Harvard Bioscience reports preliminary Q4 revenue $23.7M


Harvard Bioscience Registration statement: Registration Filing

Jan 30, 2026, 7:00 AM EST - 3 months ago

Harvard Bioscience Registration statement: Registration Filing


Harvard Bioscience Proxy statement: Proxy Filing

Jan 30, 2026, 7:00 AM EST - 3 months ago

Harvard Bioscience Proxy statement: Proxy Filing


Harvard Bioscience Proxy statement: Proxy Filing

Jan 20, 2026, 7:00 AM EST - 4 months ago

Harvard Bioscience Proxy statement: Proxy Filing


Harvard Bioscience Earnings Call Transcript: Q3 2025

Nov 6, 2025, 8:00 AM EST - 6 months ago

Harvard Bioscience Earnings Call Transcript: Q3 2025


Harvard Bioscience Quarterly report: Q3 2025

Nov 6, 2025, 8:00 AM EST - 6 months ago

Harvard Bioscience Quarterly report: Q3 2025


Harvard Bioscience Earnings release: Q3 2025

Nov 6, 2025, 8:00 AM EST - 6 months ago

Harvard Bioscience Earnings release: Q3 2025


Harvard Bioscience Slides: Q3 2025

Nov 6, 2025, 8:00 AM EST - 6 months ago

Harvard Bioscience Slides: Q3 2025


Harvard Bioscience sees Q4 revenue $22.5M-$24.5M

2025-11-06T12:13:13.000Z - 6 months ago

Harvard Bioscience sees Q4 revenue $22.5M-$24.5M


Harvard Bioscience Earnings Call Transcript: Q2 2025

Aug 11, 2025, 8:00 AM EDT - 10 months ago

Harvard Bioscience Earnings Call Transcript: Q2 2025


Harvard Bioscience Quarterly report: Q2 2025

Aug 11, 2025, 8:00 AM EDT - 10 months ago

Harvard Bioscience Quarterly report: Q2 2025


Harvard Bioscience Earnings release: Q2 2025

Aug 11, 2025, 8:00 AM EDT - 10 months ago

Harvard Bioscience Earnings release: Q2 2025


Harvard Bioscience Slides: Q2 2025

Aug 11, 2025, 8:00 AM EDT - 10 months ago

Harvard Bioscience Slides: Q2 2025


Harvard Bioscience Announces Second Quarter 2025 Financial Results

Aug 11, 2025, 7:00 AM EDT - 10 months ago

Harvard Bioscience Announces Second Quarter 2025 Financial Results


Harvard Bioscience Appoints John Duke to Board of Directors

Jun 2, 2025, 4:57 PM EDT - 1 year ago

Harvard Bioscience Appoints John Duke to Board of Directors


Harvard Bioscience Earnings Call Transcript: Q1 2025

May 12, 2025, 8:00 AM EDT - 1 year ago

Harvard Bioscience Earnings Call Transcript: Q1 2025


Harvard Bioscience Quarterly report: Q1 2025

May 12, 2025, 8:00 AM EDT - 1 year ago

Harvard Bioscience Quarterly report: Q1 2025


Harvard Bioscience Earnings release: Q1 2025

May 12, 2025, 8:00 AM EDT - 1 year ago

Harvard Bioscience Earnings release: Q1 2025


Harvard Bioscience Slides: Q1 2025

May 12, 2025, 8:00 AM EDT - 1 year ago

Harvard Bioscience Slides: Q1 2025


Harvard Bioscience Proxy statement: Proxy Filing

Apr 21, 2025, 8:00 AM EDT - 1 year ago

Harvard Bioscience Proxy statement: Proxy Filing


Harvard Bioscience Proxy statement: Proxy Filing

Apr 21, 2025, 8:00 AM EDT - 1 year ago

Harvard Bioscience Proxy statement: Proxy Filing


Harvard Bioscience Announces CFO Transition

Apr 10, 2025, 4:45 PM EDT - 1 year ago

Harvard Bioscience Announces CFO Transition


Harvard Bioscience Transcript: 37th Annual ROTH Conference

Mar 17, 2025, 1:00 PM EDT - 1 year ago

Harvard Bioscience Transcript: 37th Annual ROTH Conference


Harvard Bioscience Slides: 37th Annual ROTH Conference

Mar 17, 2025, 1:00 PM EDT - 1 year ago

Harvard Bioscience Slides: 37th Annual ROTH Conference


Harvard Bioscience Earnings Call Transcript: Q4 2024

Mar 12, 2025, 8:00 AM EDT - 1 year ago

Harvard Bioscience Earnings Call Transcript: Q4 2024


Harvard Bioscience Annual report: Q4 2024

Mar 12, 2025, 8:00 AM EDT - 1 year ago

Harvard Bioscience Annual report: Q4 2024


Harvard Bioscience Earnings release: Q4 2024

Mar 12, 2025, 8:00 AM EDT - 1 year ago

Harvard Bioscience Earnings release: Q4 2024


Harvard Bioscience Slides: Q4 2024

Mar 12, 2025, 8:00 AM EDT - 1 year ago

Harvard Bioscience Slides: Q4 2024


Harvard Bioscience Slides: Sidoti Micro-Cap Virtual Conference

Jan 22, 2025, 10:00 AM EST - 1 year ago

Harvard Bioscience Slides: Sidoti Micro-Cap Virtual Conference


Harvard Bioscience Earnings Call Transcript: Q3 2024

Nov 7, 2024, 8:00 AM EST - 1 year ago

Harvard Bioscience Earnings Call Transcript: Q3 2024


Harvard Bioscience Quarterly report: Q3 2024

Nov 7, 2024, 8:00 AM EST - 1 year ago

Harvard Bioscience Quarterly report: Q3 2024


Harvard Bioscience Earnings release: Q3 2024

Nov 7, 2024, 8:00 AM EST - 1 year ago

Harvard Bioscience Earnings release: Q3 2024


Harvard Bioscience Slides: Q3 2024

Nov 7, 2024, 8:00 AM EST - 1 year ago

Harvard Bioscience Slides: Q3 2024


Harvard Bioscience Earnings Call Transcript: Q2 2024

Aug 8, 2024, 10:00 AM EDT - 1 year ago

Harvard Bioscience Earnings Call Transcript: Q2 2024


Harvard Bioscience Quarterly report: Q2 2024

Aug 8, 2024, 10:00 AM EDT - 1 year ago

Harvard Bioscience Quarterly report: Q2 2024


Harvard Bioscience Earnings release: Q2 2024

Aug 8, 2024, 10:00 AM EDT - 1 year ago

Harvard Bioscience Earnings release: Q2 2024


Harvard Bioscience Slides: Q2 2024

Aug 8, 2024, 10:00 AM EDT - 1 year ago

Harvard Bioscience Slides: Q2 2024


Harvard Bioscience Earnings Call Transcript: Q1 2024

May 7, 2024, 8:00 AM EDT - 2 years ago

Harvard Bioscience Earnings Call Transcript: Q1 2024


Harvard Bioscience Quarterly report: Q1 2024

May 7, 2024, 8:00 AM EDT - 2 years ago

Harvard Bioscience Quarterly report: Q1 2024


Harvard Bioscience Earnings release: Q1 2024

May 7, 2024, 8:00 AM EDT - 2 years ago

Harvard Bioscience Earnings release: Q1 2024


Harvard Bioscience Slides: Q1 2024

May 7, 2024, 8:00 AM EDT - 2 years ago

Harvard Bioscience Slides: Q1 2024


Harvard Bioscience Proxy statement: Proxy Filing

Apr 3, 2024, 8:00 AM EDT - 2 years ago

Harvard Bioscience Proxy statement: Proxy Filing


Harvard Bioscience Proxy statement: Proxy Filing

Apr 3, 2024, 8:00 AM EDT - 2 years ago

Harvard Bioscience Proxy statement: Proxy Filing


Harvard Bioscience Earnings Call Transcript: Q4 2023

Mar 7, 2024, 8:00 AM EST - 2 years ago

Harvard Bioscience Earnings Call Transcript: Q4 2023


Harvard Bioscience Annual report: Q4 2023

Mar 7, 2024, 8:00 AM EST - 2 years ago

Harvard Bioscience Annual report: Q4 2023


Harvard Bioscience Earnings release: Q4 2023

Mar 7, 2024, 8:00 AM EST - 2 years ago

Harvard Bioscience Earnings release: Q4 2023


Harvard Bioscience Slides: Q4 2023

Mar 7, 2024, 8:00 AM EST - 2 years ago

Harvard Bioscience Slides: Q4 2023


Harvard Bioscience Earnings Call Transcript: Q3 2023

Nov 7, 2023, 8:00 AM EST - 2 years ago

Harvard Bioscience Earnings Call Transcript: Q3 2023


Harvard Bioscience Quarterly report: Q3 2023

Nov 7, 2023, 8:00 AM EST - 2 years ago

Harvard Bioscience Quarterly report: Q3 2023


Harvard Bioscience Earnings release: Q3 2023

Nov 7, 2023, 8:00 AM EST - 2 years ago

Harvard Bioscience Earnings release: Q3 2023


Harvard Bioscience Slides: Q3 2023

Nov 7, 2023, 8:00 AM EST - 2 years ago

Harvard Bioscience Slides: Q3 2023


Harvard Bioscience Earnings Call Transcript: Q2 2023

Aug 8, 2023, 8:00 AM EDT - 3 years ago

Harvard Bioscience Earnings Call Transcript: Q2 2023


Harvard Bioscience Quarterly report: Q2 2023

Aug 8, 2023, 8:00 AM EDT - 3 years ago

Harvard Bioscience Quarterly report: Q2 2023


Harvard Bioscience Earnings release: Q2 2023

Aug 8, 2023, 8:00 AM EDT - 3 years ago

Harvard Bioscience Earnings release: Q2 2023


Harvard Bioscience Slides: Q2 2023

Aug 8, 2023, 8:00 AM EDT - 3 years ago

Harvard Bioscience Slides: Q2 2023


Axen7
Axen7 May. 12 at 6:19 PM
$HBIO glad sold when I did. Was not a fan of this earnings. Increased debt was not what I wanted. It was a classic pump into earnings followed by a sell off. GL here though bulls
0 · Reply
SuperGreenToday
SuperGreenToday May. 12 at 12:38 PM
$HBIO Share Price: $6.89 Contract Selected: Aug 21, 2026 $4.0 Calls Buy Zone: $0.04 – $0.05 Target Zone: $0.07 – $0.08 Potential Upside: 67% ROI Time to Expiration: 100 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
EarningsInsider
EarningsInsider May. 12 at 12:31 PM
https://www.marketbeat.com/earnings/reports/2026-5-12-harvard-bioscience-inc-stock/ $HBIO Harvard Bioscience Earnings Transcript
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 12 at 11:36 AM
$HBIO Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.08 up 99.30% YoY • Reported revenue of $20.75M down -4.68% YoY • Harvard Bioscience reaffirms full-year 2026 guidance, anticipating revenue growth of 2% to 4%, adjusted gross margin of 58% to 60%, and adjusted EBITDA growth of 6% to 10%.
0 · Reply
Axen7
Axen7 May. 6 at 5:30 PM
$HBIO I am outtie all. Taking my profits finally. The low volume and uptrend is kind of reminding me of another stock I didn’t sell, for it to just get halved by an offering by the company in seconds. Gl to all here and crush it.
1 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 28 at 2:24 PM
$HBIO RSI: 60.36, MACD: 0.4121 Vol: 0.83, MA20: 5.80, MA50: 5.57 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Axen7
Axen7 Apr. 21 at 4:01 PM
$HBIO stop do the go down. Do the go up!
0 · Reply
Don_Frye
Don_Frye Apr. 20 at 7:10 PM
$NKTR $OTLK $HBIO $BYND what a day
0 · Reply
GTMStox
GTMStox Apr. 20 at 2:37 PM
$HBIO Looks like we got some volume coming in today
0 · Reply
Axen7
Axen7 Apr. 17 at 3:01 PM
$HBIO do the thing and don’t stops! Release some banger news for us one time!
0 · Reply
WestVirginian
WestVirginian Apr. 15 at 10:26 PM
$HBIO it moves with such little volume. Just waiting it out
0 · Reply
Axen7
Axen7 Apr. 13 at 4:53 PM
$HBIO do the thing now! Bang to 10 dollars you won’t 🫡
0 · Reply
BigggD
BigggD Apr. 10 at 6:56 PM
$HBIO buy the fear
0 · Reply
GTMStox
GTMStox Apr. 10 at 6:52 PM
$HBIO After all that insider buying...this is what we get. Nonsense. Added.
0 · Reply
Axen7
Axen7 Apr. 10 at 3:38 PM
$HBIO oof… 😥
0 · Reply
Axen7
Axen7 Apr. 10 at 1:50 PM
$HBIO lmao someone dumped on low volume into market and got SLAUGHTERED by the bid/ask. And now it’s been bought back up. If you had a buy set at 4.5 thank them for their donations
0 · Reply
Axen7
Axen7 Apr. 6 at 4:16 PM
0 · Reply
GTMStox
GTMStox Apr. 2 at 3:51 PM
$HBIO How is this going un-noticed??!!
1 · Reply
Axen7
Axen7 Apr. 2 at 3:00 PM
$HBIO one day!!
0 · Reply
PaidPiper
PaidPiper Mar. 27 at 1:37 AM
$HBIO Adaptimmune filed a 'change of address' wednesday. Right next door to Immunocore. Deal coming soon. This isn't spam, you won't hear from me again. Godspeed.
1 · Reply
InTheMoney_
InTheMoney_ Mar. 23 at 6:47 PM
$SPY $QQQ $LLY —> $HBIO low market cap, low watchers, and insiders cluster buying http://finshort.com/insiders
0 · Reply
mirage282828
mirage282828 Mar. 20 at 9:55 AM
$HBIO so my May 15th calls they're still the same are they going to get adjusted or not does anybody have any information
1 · Reply